Survey: Consumers Want Healthcare Price Information, But Few Realize It’s Available

Share on Facebook
Share on Twitter
Share on

State law, online tools are examples of the progress, but there’s more to do

BOSTON – Great strides have been made to increase healthcare price transparency through online cost estimator tools and a state law that requires providers to give out price information. Yet despite the eagerness of consumers to access prices and out-of-pocket costs, many are unaware that such information is available and don’t know how to access it, according to survey results published by Pioneer Institute.

“Consumers say they want price information, but only a small portion of people know they have access to it,” said Barbara Anthony, who authored “Healthcare Price Transparency in Massachusetts: Results from a survey of Massachusetts consumers regarding healthcare price transparency,” with Seher Chowdhury. “The gap between aspirations and the ability to actually obtain price information must be filled.”

DAPA Research at Suffolk University surveyed 500 adults in Massachusetts who obtain their insurance through employers or on the open market between June 15th and 23rd of 2019. Most results are at a 96 percent confidence level. Here is a summary of the findings:

Satisfaction with insurers and deductibles

Three quarters of Massachusetts consumers with private commercial insurance said they were satisfied or very satisfied with their coverage. Yet 64 percent of those expressing satisfaction with their coverage still worry about healthcare costs.

Seventy-six percent of respondents either have no deductible of a deductible of $3,000 or less. Eleven percent have deductibles greater than $3,000, and 12 percent don’t know their deductible.

Twenty-three percent said they had chosen not to obtain necessary healthcare in the last three years due to cost. It appears, however, that deductible size may not be the primary reason for deferring care, since 80 percent of those who did so had deductibles of less than $3,000. Deferring necessary care can lead to poorer and more expensive health outcomes.

Finding healthcare prices

Only one in five Massachusetts consumers have tried to find price information before obtaining a healthcare service. It’s not that they aren’t interested; rather, it appears that consumers don’t know they have a right to such information under state law and they don’t know how to access it.

Seven in ten consumers said they would like to know prices, but about the same percentage didn’t know insurance carriers have price estimator tools they could use to find them.

A majority said they had never thought of trying to obtain healthcare price information.

Respondents said the sources they would trust the most for price information were, in order, their insurance company, their doctor, and the Commonwealth of Massachusetts.

Incentives to choose less expensive providers

When asked a series of questions about what would help incent them to choose lower-cost providers, nearly seven out of 10 said physician or hospital websites that show out-of-pocket costs. About two thirds cited cash-back rewards form their insurer for choosing less expensive providers. A similar percentage wanted notifications from insurers about less expensive providers for specific services.

Eight of ten respondents were interested in doctor and hospital quality ratings. Three out of four wanted to know the reimbursement amounts insurers paid to doctors and hospitals for specific health services. Two thirds said an iPhone app that shows specific out-of-pocket costs would help.


Anthony and Chowdhury call for all providers to be more innovative in making price information available in consumer-friendly formats. Physician practices and hospital administrators should be trained to help patients navigate cost estimator tools and insurers should more aggressively market the tools while continuing to make them more customer friendly.

They also called on the Commonwealth to use its bully pulpit and assert more leadership in promoting price transparency and educating businesses, consumers, insurers, and providers. Similarly, insurance companies and employers should work together to educate members and employees about the availability of pricing information.

Finally, high satisfaction with current health insurance equates to a great opportunity for carriers to educate and incentivize cost consciousness among their members.

About the Authors

Barbara Anthony, lawyer, economist, and public policy expert, is a Senior Fellow in Healthcare Policy at Pioneer Institute. She was also a former Senior Fellow and Associate at the Harvard Kennedy School’s Center for Business and Government where she researched and wrote about Massachusetts market reform and healthcare cost containment efforts. She served as Massachusetts Undersecretary of the Office of Consumer Affairs and Business Regulation from 2009 to 2015 and has worked at the intersection of federal and state commercial regulation and the business community for many years.  Anthony’s work has appeared in numerous state and national publications.

Seher Chowdhury graduated this Spring from the Boston University School of Public Health (BUSPH) with a Masters Degree in Public Health; her areas of specialization include Health Policy & law and Epidemiology and Biostatis­tics. She has been a Pioneer Research Assistant in Healthcare Policy since June 2019. She has worked extensively in the area of healthcare price transparency along with Pioneer’s Senior Fellows. She participated extensively in Pioneer’s first state poll and analysis of consumers’ attitudes toward healthcare price transparency. Outside of price transparency, her areas of interest include Med­icaid reform and expansion; reproductive and minority health access and equity; and the inter­section of health, human rights, and bioethics. Seher graduated from the University of California at Los Angeles (UCLA) in 2018 with a Bachelor of Science degree, where she completed a major in Biology and minor in Asian Languages (Korean concentration).

About Pioneer


Pioneer Institute develops and communicates dynamic ideas that advance prosperity and a vibrant civic life in Massachusetts and beyond.


Success for Pioneer is when the citizens of our state and nation prosper and our society thrives because we enjoy world-class options in education, healthcare, transportation and economic opportunity, and when our government is limited, accountable and transparent.


Pioneer believes that America is at its best when our citizenry is well-educated, committed to liberty, personal responsibility, and free enterprise, and both willing and able to test their beliefs based on facts and the free exchange of ideas.

Get Updates On Our Healthcare Cost Transparency Initiative!

Related Posts:

New Online Tool Tracks MA Hospital Revenue from Commercial Sources

A new online tool from Pioneer Institute shows a gradual increase in non-commercial (public payer) revenue at Massachusetts hospitals and also reveals a strong relationship between the hospitals with the highest commercial revenue and those with the highest relative prices.

Telehealth Progress Slowed in 2023

A new report by Cicero Institute, Pioneer Institute, and Reason Foundation reveals worrying stagnation in state-level telehealth expansion efforts in 2023, with only a few exceptions. Progress made during the pandemic is being lost even as provider shortages worsen, raising concerns about patients’ access to care.

Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.

Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions only come when inventors are rewarded, not punished. Patents are not a “necessary evil.”

Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Study: Massachusetts Should Join 45 States and Allow Prescribers to Dispense Medications

A Pioneer Institute study shows that middlemen—commercial pharmacies and pharmacy benefit managers—add substantial costs over wholesale prices. Allowing prescribers to dispense routine drugs would save consumers money without compromising safety.

As COVID-19 Emergencies Ease, Some Progress on Telehealth Rules

A new report from Reason Foundation, Cicero Institute and Pioneer Institute rates every state’s telehealth policy for patient access and ease of providing virtual care. The report highlights telehealth policy best practices for states.

First-of-Its-Kind Interactive Mapping Tool Reveals Extent of For-Profit Entities Benefitting from the 340B Drug Pricing Program

Today, Pioneer Institute released a first-of-its-kind, 50-state mapping tool and database highlighting the troubling way in which hospitals and covered entities leverage unlimited pharmacy contracts under the 340B Drug Pricing Program.

Survey Finds Spotty Compliance Among Hospitals with Federal Price Transparency Law

A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.

The Promise and Challenges of Rare Cancer Treatments

Dr. William Smith, Pioneer Institute's Visiting Fellow in Life Sciences, spoke about the challenges and opportunities for rare cancer treatments, in a video interview produced by Rare Cancers, a patient group based in Australia, for the November 26th CAN Forum. 

Study: Decline in Cardiovascular Health Screenings During COVID-19 Pandemic Poses New Public Health Threat

Pioneer Institute today released a new analysis focused on cardiovascular disease, An “Impending Tsunami” in Mortality from Traditional Diseases?, that examines how the COVID-19 pandemic has created another unrelated public health crisis. The Pioneer analysis examines how a single-minded public health focus on COVID-19, social distancing, and lockdowns drove reductions in screenings, diagnoses, and early treatment for complex conditions such as heart disease.

Pioneer Institute Statement on the Commonwealth’s Discontinuance of the COVID-19 Weekly Public Health Report

Useful information about COVID cases or deaths at individual homes has become less available at a time when cases are increasing again, even among vaccinated residents. Pioneer urges Massachusetts to immediately reinstate the so-called Weekly Report, which contains cases and deaths inside individual nursing homes.